Abstract
Abstract
Background
The AIDS Healthcare Foundation (AHF-Checkpoint) in The Netherlands offers rapid HIV testing for key populations by lay providers. We explored the experiences and needs of lay providers and end users of HIV testing at AHF-Checkpoint, taking into account the WHO 5C-(consent, confidentiality, counselling, correct-results, connection-to-care) criteria for HIV test services.
Methods
Qualitative evaluation with 15 semi-structured interviews conducted during 2020 with ten lay providers and five gay or bisexual end users. Recorded interviews were thematically analysed, taking data triangulation into account.
Results
Four domains were identified: (1) accessibility of HIV testing, (2) quality of test procedures, (3) bridging (transitional care), and (4) future strategies for service delivery. AHF-Checkpoint fills a gap for key populations including LGBTQ and refugees, who experience HIV testing barriers at sexual health centres or general practices. The level of trust between lay providers and end users was highly valued by end users. They appreciated the low threshold to test at no costs, and the absence of waiting lists or triaging. Needs expressed by lay providers included more preparedness for emotionally charged situations, and extra training to improve STI knowledge. End users expressed a need for a full STI test package. Of the 5Cs, consent, counselling, and correct results were realised but confidentiality was sometimes difficult to achieve at pop-up locations, and referral barriers for confirmation testing (connection-to-care) were occasionally experienced by lay providers during weekends.
Conclusion
AHF-Checkpoint was described as a convenient and easily accessible service by end users and lay providers. Of the WHO 5Cs, connection-to-care could be optimised to ensure HIV confirmation and STI testing through a liaison approach with professionals from the regular healthcare sector.
Funder
Ministerie van Volksgezondheid, Welzijn en Sport
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Virology,Molecular Medicine
Reference36 articles.
1. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Report 2016. https://apps.who.int/iris/handle/10665/208825. Accessed 4 June 2021.
2. UNAIDS. Prevailing against pandemics. Report 2020. https://aidstargets2025.unaids.org/assets/images/prevailing-against-pandemics_en.pdf. Accessed 4 June 2021.
3. Van Sighem AI, de Wit FWNM, Boyd A, Smit C, Matser A, Reiss P. Monitoring Report 2019. Human Immunodeficiency Virus (HIV) Infection in The Netherlands. Amsterdam: Stichting HIV Monitoring, 2019. http://www.hiv-monitoring.nl. Accessed 4 June 2021.
4. David S, Van Benthem B, Deug F, van Haastrecht P. Report 2018. National Action Plan on STIs, HIV and Sexual Health: 2017–2022. https://www.rivm.nl/publicaties/national-action-plan-on-stis-hiv-and-sexual-health-2017-2022. Accessed 4 June 2021.
5. Visser M, Van Aar F, Op de Coul E, Slurink I, Van Wees D, Hoenderboom B, et al. Sexually transmitted infections in The Netherlands in 2017. RIVM report number: 2018-0012. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2018. https://doi.org/10.21945/RIVM-2018-0012.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献